Atypical Course of SarsCov-2 Infection in a Patient with Multiple Myeloma Treated with Autologous Stem Cell Transplantation

Gianluca Isaia; Silvia Valerio; Stefania Oliva; Enrico Brunetti; Mario Bo

doi:10.18502/ijhoscr.v17i2.12652

Atypical Course of SarsCov-2 Infection in a Patient with Multiple Myeloma Treated with Autologous Stem Cell Transplantation

Int J Hematol Oncol Stem Cell Res. 2023 Apr 1;17(2):128-131. doi: 10.18502/ijhoscr.v17i2.12652.

Authors

Gianluca Isaia¹, Silvia Valerio¹, Stefania Oliva², Enrico Brunetti¹, Mario Bo¹

Affiliations

¹ Section of Geriatrics, Department of Medical Sciences, Università degli Studi di Torino, A.O.U. Città della Salute e della Scienza di Torino, Molinette, Corso Bramante 88, 10126, Turin, Italy.
² Department of Oncology, Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.

Abstract

Covid-19 infection has more relevant consequences in frail and comorbid patients, but little is known about its course in patients with hematologic malignancies. In this report, we would like to present the case of a patient with multiple myeloma treated with recent autologous bone marrow stem cell transplantation and affected by Covid-19 pneumonia, presenting with a possible reinfection or an extremely long viral shedding.

Keywords: Covid-19; Hematopoietic stem cell transplantation; Multiple myeloma.

Publication types

Case Reports